MCM3AP and posterior cortical atrophy: It was found that MCM3AP-AS1 is an important target for PCA metastasis and improve poor prognosis, and valproic acid and trichostatin A may be potential therapeutic agents for PCA by reversing the expression level of MCM3AP-AS1 [51].